| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | PLCZ1 FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 MATN2 FAT3 RET TBC1D8B RYR3 DCHS1 MACF1 PLCD1 CDH16 | 8.55e-05 | 749 | 172 | 18 | GO:0005509 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 RET AMIGO1 DCHS1 CDH16 | 7.01e-09 | 187 | 174 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 RET AMIGO1 TGFB2 DCHS1 MDGA1 CDH16 | 7.11e-08 | 313 | 174 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 3.82e-05 | 23 | 174 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FAT4 ITGA11 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 ITGA10 RET DCC UBASH3A NLRP3 AMIGO1 TGFB2 HHLA2 SASH3 DCHS1 LRRC7 MDGA1 CDH16 | 3.90e-05 | 1077 | 174 | 23 | GO:0098609 |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 4.56e-05 | 24 | 174 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | uterine wall breakdown | 7.08e-05 | 2 | 174 | 2 | GO:0042704 | |
| Domain | Cadherin | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 RET DCHS1 CDH16 | 7.28e-10 | 113 | 176 | 12 | PF00028 |
| Domain | CADHERIN_2 | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 RET DCHS1 CDH16 | 8.07e-10 | 114 | 176 | 12 | PS50268 |
| Domain | - | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 RET DCHS1 CDH16 | 8.07e-10 | 114 | 176 | 12 | 2.60.40.60 |
| Domain | CA | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 RET DCHS1 CDH16 | 8.94e-10 | 115 | 176 | 12 | SM00112 |
| Domain | Cadherin-like | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 RET DCHS1 CDH16 | 9.89e-10 | 116 | 176 | 12 | IPR015919 |
| Domain | Cadherin | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 RET DCHS1 CDH16 | 1.21e-09 | 118 | 176 | 12 | IPR002126 |
| Domain | Cadherin_CS | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 DCHS1 CDH16 | 6.56e-09 | 109 | 176 | 11 | IPR020894 |
| Domain | DCB_dom | 7.62e-09 | 4 | 176 | 4 | IPR032629 | |
| Domain | Sec7_C | 7.62e-09 | 4 | 176 | 4 | IPR015403 | |
| Domain | DUF1981 | 7.62e-09 | 4 | 176 | 4 | PF09324 | |
| Domain | Sec7_N | 7.62e-09 | 4 | 176 | 4 | IPR032691 | |
| Domain | Sec7_N | 7.62e-09 | 4 | 176 | 4 | PF12783 | |
| Domain | DCB | 7.62e-09 | 4 | 176 | 4 | PF16213 | |
| Domain | CADHERIN_1 | FAT4 PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 FAT3 DCHS1 CDH16 | 9.62e-09 | 113 | 176 | 11 | PS00232 |
| Domain | Cadherin_tail | 4.75e-08 | 37 | 176 | 7 | PF15974 | |
| Domain | Cadherin_CBD | 4.75e-08 | 37 | 176 | 7 | IPR031904 | |
| Domain | Cadherin_C | 2.55e-06 | 42 | 176 | 6 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.55e-06 | 42 | 176 | 6 | PF16492 | |
| Domain | Cadherin_2 | 2.57e-06 | 65 | 176 | 7 | PF08266 | |
| Domain | Cadherin_N | 2.57e-06 | 65 | 176 | 7 | IPR013164 | |
| Domain | ConA-like_dom | PAPPA2 FAT4 COL15A1 COL20A1 FAT3 TRIM64 RYR3 TRIM64B HNRNPUL2 HERC1 MDGA1 | 7.55e-06 | 219 | 176 | 11 | IPR013320 |
| Domain | SEC7 | 1.27e-05 | 16 | 176 | 4 | PS50190 | |
| Domain | Sec7 | 1.27e-05 | 16 | 176 | 4 | SM00222 | |
| Domain | Sec7_dom | 1.27e-05 | 16 | 176 | 4 | IPR000904 | |
| Domain | SWIM | 2.80e-05 | 7 | 176 | 3 | PF04434 | |
| Domain | Leu-rich_rpt | MFHAS1 LRRC70 ADGRA2 NLRP3 AMIGO1 LRRC52 NLRP9 NLRP14 TLR4 LRRC7 ADGRA3 | 5.42e-05 | 271 | 176 | 11 | IPR001611 |
| Domain | ZF_SWIM | 6.63e-05 | 9 | 176 | 3 | PS50966 | |
| Domain | Znf_SWIM | 6.63e-05 | 9 | 176 | 3 | IPR007527 | |
| Domain | ARM-type_fold | MON2 VPS11 GBF1 NOC3L ARFGEF2 ARFGEF1 TMCO6 APOB RYR3 ARFGEF3 ASPM PRKDC | 9.26e-05 | 339 | 176 | 12 | IPR016024 |
| Domain | VWA | 1.82e-04 | 56 | 176 | 5 | PF00092 | |
| Domain | LRR_8 | 2.21e-04 | 171 | 176 | 8 | PF13855 | |
| Domain | - | MFHAS1 LRRC70 ADGRA2 NLRP3 AMIGO1 LRRC52 NLRP9 NLRP14 TLR4 LRRC7 ADGRA3 | 2.41e-04 | 321 | 176 | 11 | 3.80.10.10 |
| Domain | TGF-beta | 2.63e-04 | 3 | 176 | 2 | IPR016319 | |
| Domain | LRR_TYP | 2.80e-04 | 177 | 176 | 8 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 2.80e-04 | 177 | 176 | 8 | IPR003591 | |
| Domain | L_dom-like | MFHAS1 LRRC70 ADGRA2 NLRP3 AMIGO1 LRRC52 NLRP9 NLRP14 TLR4 LRRC7 ADGRA3 | 2.90e-04 | 328 | 176 | 11 | IPR032675 |
| Domain | - | 3.44e-04 | 15 | 176 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 3.44e-04 | 15 | 176 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 3.44e-04 | 15 | 176 | 3 | IPR023394 | |
| Domain | P-loop_NTPase | RAD51B DDX31 MFHAS1 MYO18A RRAGB PAPSS2 GTPBP10 NLRP3 DHX30 NLRP9 NLRP14 NWD2 ABCB9 HNRNPUL2 RHEBL1 ASPM ABCD1 AGAP9 DNA2 | 4.19e-04 | 848 | 176 | 19 | IPR027417 |
| Domain | - | 5.23e-04 | 4 | 176 | 2 | 3.90.1460.10 | |
| Domain | Pecanex_C | 5.23e-04 | 4 | 176 | 2 | PF05041 | |
| Domain | SPHK1-interactor_AKAP_110 | 5.23e-04 | 4 | 176 | 2 | IPR008382 | |
| Domain | GTF2I | 5.23e-04 | 4 | 176 | 2 | PS51139 | |
| Domain | GTF2I | 5.23e-04 | 4 | 176 | 2 | PF02946 | |
| Domain | AKAP_110 | 5.23e-04 | 4 | 176 | 2 | PF05716 | |
| Domain | Pecanex | 5.23e-04 | 4 | 176 | 2 | IPR007735 | |
| Domain | GTF2I | 5.23e-04 | 4 | 176 | 2 | IPR004212 | |
| Domain | LRR | 6.51e-04 | 201 | 176 | 8 | PS51450 | |
| Domain | - | RAD51B DDX31 MFHAS1 MYO18A RRAGB PAPSS2 GTPBP10 DHX30 NLRP9 NLRP14 NWD2 ABCB9 HNRNPUL2 RHEBL1 ABCD1 AGAP9 DNA2 | 7.05e-04 | 746 | 176 | 17 | 3.40.50.300 |
| Domain | VWFA | 1.07e-03 | 82 | 176 | 5 | PS50234 | |
| Domain | DAPIN | 1.11e-03 | 22 | 176 | 3 | PS50824 | |
| Domain | PYRIN | 1.11e-03 | 22 | 176 | 3 | SM01289 | |
| Domain | PYRIN | 1.11e-03 | 22 | 176 | 3 | PF02758 | |
| Domain | DAPIN | 1.11e-03 | 22 | 176 | 3 | IPR004020 | |
| Domain | LRR_1 | 1.14e-03 | 219 | 176 | 8 | PF00560 | |
| Domain | VWA | 1.19e-03 | 84 | 176 | 5 | SM00327 | |
| Domain | NACHT | 1.27e-03 | 23 | 176 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 1.27e-03 | 23 | 176 | 3 | IPR007111 | |
| Domain | FAST_2 | 1.29e-03 | 6 | 176 | 2 | PF08368 | |
| Domain | RAP | 1.29e-03 | 6 | 176 | 2 | SM00952 | |
| Domain | RAP | 1.29e-03 | 6 | 176 | 2 | PF08373 | |
| Domain | RAP | 1.29e-03 | 6 | 176 | 2 | PS51286 | |
| Domain | FAST_1 | 1.29e-03 | 6 | 176 | 2 | PF06743 | |
| Domain | FAST_Leu-rich | 1.29e-03 | 6 | 176 | 2 | IPR010622 | |
| Domain | FAST_2 | 1.29e-03 | 6 | 176 | 2 | IPR013579 | |
| Domain | RAP | 1.29e-03 | 6 | 176 | 2 | IPR013584 | |
| Domain | SPRY | 1.39e-03 | 87 | 176 | 5 | SM00449 | |
| Domain | Cys-rich_flank_reg_C | 1.62e-03 | 90 | 176 | 5 | IPR000483 | |
| Domain | LRRCT | 1.62e-03 | 90 | 176 | 5 | SM00082 | |
| Domain | LRR_6 | 1.79e-03 | 55 | 176 | 4 | PF13516 | |
| Domain | SPRY | 1.96e-03 | 94 | 176 | 5 | PF00622 | |
| Domain | SPRY_dom | 1.96e-03 | 94 | 176 | 5 | IPR003877 | |
| Domain | B30.2/SPRY | 2.05e-03 | 95 | 176 | 5 | IPR001870 | |
| Domain | B302_SPRY | 2.05e-03 | 95 | 176 | 5 | PS50188 | |
| Domain | Laminin_G | 2.18e-03 | 58 | 176 | 4 | IPR001791 | |
| Domain | VWF_A | 2.46e-03 | 99 | 176 | 5 | IPR002035 | |
| Domain | LamG | 8.21e-03 | 44 | 176 | 3 | SM00282 | |
| Domain | Collagen | 8.53e-03 | 85 | 176 | 4 | IPR008160 | |
| Domain | Collagen | 8.53e-03 | 85 | 176 | 4 | PF01391 | |
| Domain | EF-hand_like | 8.55e-03 | 15 | 176 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 8.55e-03 | 15 | 176 | 2 | PF00387 | |
| Domain | PLCYc | 8.55e-03 | 15 | 176 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 8.55e-03 | 15 | 176 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 8.55e-03 | 15 | 176 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 8.55e-03 | 15 | 176 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 8.55e-03 | 15 | 176 | 2 | IPR015359 | |
| Domain | Cyt_P450_E_grp-I | 8.73e-03 | 45 | 176 | 3 | IPR002401 | |
| Domain | - | AGAP5 TRPA1 ANKRD20A2P ANKRD20A3P ANKRD20A4P AGAP9 ANKRD20A1 | 9.26e-03 | 248 | 176 | 7 | 1.25.40.20 |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 4.89e-08 | 8 | 181 | 4 | 12634303 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 6.83e-08 | 68 | 181 | 7 | 11230163 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.02e-07 | 72 | 181 | 7 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 1.23e-07 | 74 | 181 | 7 | 10817752 | |
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 19332778 | ||
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 23386609 | ||
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 18003980 | ||
| Pubmed | RAD51B PCDHGC4 COL20A1 PCDHGA10 ZSWIM5 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 NOC3L MYO18A APOB DCC KIAA2013 TASOR2 GTF2IRD2B ABCB9 ASPM GTF2IRD2 DNAJC5 MACF1 PRKDC TUBD1 HSP90AB1 | 1.41e-07 | 1442 | 181 | 25 | 35575683 | |
| Pubmed | 1.63e-07 | 77 | 181 | 7 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 2.12e-07 | 80 | 181 | 7 | 10716726 | |
| Pubmed | Betaglycan is required for the establishment of nephron endowment in the mouse. | 9.26e-07 | 15 | 181 | 4 | 21533152 | |
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 25683715 | ||
| Pubmed | Tgf-beta-mediated FasL-Fas-Caspase pathway is crucial during palatogenesis. | 1.38e-06 | 5 | 181 | 3 | 21593251 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 1.40e-06 | 67 | 181 | 6 | 21875946 | |
| Pubmed | 1.72e-06 | 210 | 181 | 9 | 16565220 | ||
| Pubmed | DMXL2 GBF1 COBLL1 PLEKHA6 MORC2 KIAA2013 AMIGO1 GDA VPS13D USF3 NUP210 MACF1 NUP160 | 2.13e-06 | 493 | 181 | 13 | 15368895 | |
| Pubmed | 4.17e-06 | 234 | 181 | 9 | 36243803 | ||
| Pubmed | RALGDS AGAP5 SATB2 PPP2R2D FASTKD2 ADGRA2 FRMD4B NPLOC4 SLC38A2 ZNF516 AKAP11 AGAP9 DNA2 | 4.57e-06 | 529 | 181 | 13 | 14621295 | |
| Pubmed | 4.78e-06 | 7 | 181 | 3 | 16059920 | ||
| Pubmed | 5.67e-06 | 183 | 181 | 8 | 23956138 | ||
| Pubmed | Hnf1b and Pax2 cooperate to control different pathways in kidney and ureter morphogenesis. | 8.24e-06 | 25 | 181 | 4 | 22511595 | |
| Pubmed | MON2 MMS22L GBF1 PPP2R2D ARFGEF1 RTN3 FASTKD5 NPLOC4 FANCI NUP210 PRKDC ZW10 NUP160 HSP90AB1 | 9.88e-06 | 657 | 181 | 14 | 36180527 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RAD51B ENC1 RTN3 ZSWIM1 ARHGEF16 NPLOC4 TASOR2 PCNX2 ARFGEF3 ARHGAP6 USF3 PTPRN2 NUP210 MACF1 LRRC7 XYLB QSER1 TANGO2 ZSWIM4 CLEC16A PDZD2 NPAS2 | 1.10e-05 | 1489 | 181 | 22 | 28611215 |
| Pubmed | Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death. | 1.14e-05 | 9 | 181 | 3 | 24799678 | |
| Pubmed | 1.72e-05 | 103 | 181 | 6 | 10819331 | ||
| Pubmed | 2.15e-05 | 64 | 181 | 5 | 22261194 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MON2 PAPPA2 COL6A2 MMS22L SLC10A3 TMC4 DCC FRMD4B FANCI ASPM | 2.26e-05 | 363 | 181 | 10 | 14691545 |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 37109509 | ||
| Pubmed | Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. | 2.69e-05 | 2 | 181 | 2 | 17079330 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 30455347 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 11488419 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 10716990 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 1375903 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 34093588 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 26254306 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 11834739 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 26555554 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 18417613 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 27321991 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 31759058 | ||
| Pubmed | Disease-related quantitation of TGF-beta3 in human aqueous humor. | 2.69e-05 | 2 | 181 | 2 | 18049952 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 37643860 | ||
| Pubmed | Low expression of TGF-β2 and matrilin2 in human aqueous humour with acute primary angle closure. | 2.69e-05 | 2 | 181 | 2 | 38235996 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 2.69e-05 | 2 | 181 | 2 | 15388857 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 38416826 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 27813491 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 25497973 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 27779191 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 23918382 | ||
| Pubmed | Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages. | 2.69e-05 | 2 | 181 | 2 | 27250627 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17360629 | ||
| Pubmed | Stromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently. | 2.69e-05 | 2 | 181 | 2 | 26990302 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 18203920 | ||
| Pubmed | Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions. | 2.69e-05 | 2 | 181 | 2 | 25355906 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 9364212 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 30522866 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 34659265 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 12466142 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 32894580 | ||
| Pubmed | Structure of the planar cell polarity cadherins Fat4 and Dachsous1. | 2.69e-05 | 2 | 181 | 2 | 36797229 | |
| Pubmed | Mammalian cadherins DCHS1-FAT4 affect functional cerebral architecture. | 2.69e-05 | 2 | 181 | 2 | 25930014 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 11984523 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 10212200 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 35459853 | ||
| Pubmed | 2.91e-05 | 113 | 181 | 6 | 30352685 | ||
| Pubmed | NODs: intracellular proteins involved in inflammation and apoptosis. | 2.95e-05 | 12 | 181 | 3 | 12766759 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EXOC6 NOC3L ARFGEF1 RTN3 FASTKD5 TBL3 KIAA2013 ARFGEF3 SLC38A2 YIF1A FANCI NUP210 PRKDC ABCD1 ZW10 HSP90AB1 | 3.69e-05 | 942 | 181 | 16 | 31073040 |
| Pubmed | Overexpression of integrin α11 induces cardiac fibrosis in mice. | 3.82e-05 | 13 | 181 | 3 | 28771943 | |
| Pubmed | RALGDS COL6A2 DMXL2 MORC2 PAPSS2 MAP3K6 NPLOC4 HNRNPUL2 AP5B1 QSER1 PZP DNA2 CLEC16A | 3.97e-05 | 650 | 181 | 13 | 38777146 | |
| Pubmed | 4.84e-05 | 14 | 181 | 3 | 20095854 | ||
| Pubmed | 4.84e-05 | 14 | 181 | 3 | 12563287 | ||
| Pubmed | 4.84e-05 | 14 | 181 | 3 | 20403135 | ||
| Pubmed | MON2 ZSWIM5 ZNF365 DHX30 EPG5 ARFGEF3 MACF1 LRRC7 CLEC16A PDZD2 | 5.91e-05 | 407 | 181 | 10 | 12693553 | |
| Pubmed | 6.02e-05 | 15 | 181 | 3 | 23515096 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 GBF1 PCNX3 MFHAS1 ARFGEF2 TMCO6 SLC10A3 ADGRA2 KIAA2013 DHX30 PCNX2 FANCI ZNF516 PRKDC ABCD1 STK40 HERC1 | 7.14e-05 | 1105 | 181 | 17 | 35748872 |
| Pubmed | MON2 DMXL2 GBF1 ARFGEF2 ARFGEF1 RTN3 ARFGEF3 SLC38A2 VPS13D AKAP11 ZW10 | 7.32e-05 | 504 | 181 | 11 | 34432599 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 19062040 | ||
| Pubmed | Activity-dependent release of transforming growth factor-beta in a neuronal network in vitro. | 8.05e-05 | 3 | 181 | 2 | 17997227 | |
| Pubmed | Specific functions of BIG1 and BIG2 in endomembrane organization. | 8.05e-05 | 3 | 181 | 2 | 20360857 | |
| Pubmed | Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy. | 8.05e-05 | 3 | 181 | 2 | 26349656 | |
| Pubmed | Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas. | 8.05e-05 | 3 | 181 | 2 | 20142847 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 33860064 | ||
| Pubmed | Posttraumatic temporal TGF-β mRNA expression in lens epithelial cells of paediatric patients. | 8.05e-05 | 3 | 181 | 2 | 22464821 | |
| Pubmed | Excess TGF-β mediates muscle weakness associated with bone metastases in mice. | 8.05e-05 | 3 | 181 | 2 | 26457758 | |
| Pubmed | Significant role for Fas in the pathogenesis of autoimmune diabetes. | 8.05e-05 | 3 | 181 | 2 | 10679090 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 8125201 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 16192636 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 29547450 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 20565961 | ||
| Pubmed | Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition. | 8.05e-05 | 3 | 181 | 2 | 29856065 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 18790002 | ||
| Pubmed | Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. | 8.05e-05 | 3 | 181 | 2 | 12021923 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 29320969 | ||
| Pubmed | Aberrant TGFβ Signaling Contributes to Altered Trophoblast Differentiation in Preeclampsia. | 8.05e-05 | 3 | 181 | 2 | 26653761 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 1723948 | ||
| Pubmed | Transforming growth factor-beta. A family of growth regulatory peptides. | 8.05e-05 | 3 | 181 | 2 | 2375595 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 14647419 | ||
| Pubmed | TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. | 8.05e-05 | 3 | 181 | 2 | 24445575 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 15021905 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 34404755 | ||
| Interaction | NPY2R interactions | 6.11e-09 | 66 | 177 | 9 | int:NPY2R | |
| Interaction | FPR1 interactions | 6.18e-06 | 147 | 177 | 9 | int:FPR1 | |
| Interaction | ANKRD20A4P interactions | 1.31e-05 | 6 | 177 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 2.27e-05 | 7 | 177 | 3 | int:ANKRD20A2P | |
| Interaction | NUP210P1 interactions | 3.23e-05 | 42 | 177 | 5 | int:NUP210P1 | |
| Cytoband | 5q31 | 4.03e-07 | 115 | 181 | 7 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHGC4 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 TMCO6 | 2.66e-05 | 298 | 181 | 8 | chr5q31 |
| Cytoband | 3p22-p21.3 | 9.23e-05 | 4 | 181 | 2 | 3p22-p21.3 | |
| Cytoband | 11q14.3 | 2.75e-04 | 32 | 181 | 3 | 11q14.3 | |
| GeneFamily | Clustered protocadherins | 3.02e-07 | 64 | 126 | 7 | 20 | |
| GeneFamily | Cadherin related | 4.99e-06 | 17 | 126 | 4 | 24 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 2.69e-05 | 9 | 126 | 3 | 90 | |
| GeneFamily | Immunoglobulin like domain containing|Adhesion G protein-coupled receptors, subfamily A | 1.44e-04 | 3 | 126 | 2 | 911 | |
| GeneFamily | Collagens | 2.93e-04 | 46 | 126 | 4 | 490 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.45e-04 | 20 | 126 | 3 | 548 | |
| GeneFamily | NLR family | 6.79e-04 | 25 | 126 | 3 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 6.79e-04 | 25 | 126 | 3 | 994 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.06e-03 | 29 | 126 | 3 | 396 | |
| GeneFamily | Ankyrin repeat domain containing | AGAP5 TRPA1 ANKRD20A2P ANKRD20A3P ANKRD20A4P AGAP9 ANKRD20A1 | 1.55e-03 | 242 | 126 | 7 | 403 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.48e-06 | 110 | 174 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 7.40e-08 | 186 | 181 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.88e-08 | 190 | 181 | 9 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.71e-08 | 192 | 181 | 9 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.12e-07 | 125 | 181 | 7 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 9.36e-07 | 185 | 181 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-07 | 186 | 181 | 8 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-07 | 186 | 181 | 8 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 188 | 181 | 8 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 189 | 181 | 8 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 189 | 181 | 8 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 190 | 181 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-06 | 190 | 181 | 8 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 191 | 181 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 191 | 181 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.19e-06 | 191 | 181 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 191 | 181 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 191 | 181 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-06 | 192 | 181 | 8 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 195 | 181 | 8 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 195 | 181 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 195 | 181 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL|Int-URO / Disease, condition lineage and cell class | 1.56e-06 | 198 | 181 | 8 | 717735d755745439f97ba1b71785c73945dfa9c5 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.63e-06 | 149 | 181 | 7 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-06 | 178 | 181 | 7 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-06 | 180 | 181 | 7 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 181 | 181 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 184 | 181 | 7 | 238eba615b4e04967d44ac7858a6673bdd7f67e9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.05e-05 | 184 | 181 | 7 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.05e-05 | 184 | 181 | 7 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 185 | 181 | 7 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 187 | 181 | 7 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 187 | 181 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 181 | 7 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 181 | 7 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.18e-05 | 124 | 181 | 6 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-05 | 124 | 181 | 6 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 189 | 181 | 7 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-05 | 126 | 181 | 6 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 190 | 181 | 7 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 191 | 181 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 191 | 181 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 192 | 181 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 194 | 181 | 7 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 194 | 181 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 195 | 181 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 195 | 181 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 195 | 181 | 7 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-05 | 195 | 181 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 130 | 181 | 6 | 8c81853c806e9a0d562e00dc5e00a8fc569a854c | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 130 | 181 | 6 | 3041d20fe964d282d95c0312396f26bc93929056 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 130 | 181 | 6 | 3b6a8eaef593db73c2fad2260b9f1e15950ccb70 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 196 | 181 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 196 | 181 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 196 | 181 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 196 | 181 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-05 | 196 | 181 | 7 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.61e-05 | 131 | 181 | 6 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 198 | 181 | 7 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 198 | 181 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.69e-05 | 198 | 181 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.81e-05 | 200 | 181 | 7 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.25e-05 | 139 | 181 | 6 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.20e-05 | 148 | 181 | 6 | c95a732163050cfb5d604c2a4c9eb1afa9f19a95 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_CTL|Int-URO / Disease, Lineage and Cell Type | 3.86e-05 | 153 | 181 | 6 | fdc7dfa8f4db90bfdc7180bf178cf6d2dd064d97 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.62e-05 | 158 | 181 | 6 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-05 | 159 | 181 | 6 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.95e-05 | 160 | 181 | 6 | 913e59cecf3b1bdd1ef32b4e320042b9bbdb54bc | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.49e-05 | 163 | 181 | 6 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 168 | 181 | 6 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.49e-05 | 168 | 181 | 6 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 169 | 181 | 6 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-05 | 171 | 181 | 6 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-05 | 171 | 181 | 6 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.16e-05 | 171 | 181 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.88e-05 | 174 | 181 | 6 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.88e-05 | 174 | 181 | 6 | 0d8e737860120dcd3a6b57992c612595904d585e | |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | 7.88e-05 | 174 | 181 | 6 | ebdddb5091afcc49ab533c890f260f709880c5f9 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.88e-05 | 174 | 181 | 6 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.13e-05 | 175 | 181 | 6 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.13e-05 | 175 | 181 | 6 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-05 | 176 | 181 | 6 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.93e-05 | 178 | 181 | 6 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.93e-05 | 178 | 181 | 6 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.21e-05 | 179 | 181 | 6 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.21e-05 | 179 | 181 | 6 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 180 | 181 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.79e-05 | 181 | 181 | 6 | c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-05 | 181 | 181 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.79e-05 | 181 | 181 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-05 | 181 | 181 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.79e-05 | 181 | 181 | 6 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 182 | 181 | 6 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 182 | 181 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 182 | 181 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-04 | 182 | 181 | 6 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 183 | 181 | 6 | 52af3c943116073c8ddd207b664342960b88929b | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.04e-04 | 183 | 181 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | RAD51B SATB2 TMCO6 PLEKHA6 MORC2 PAPSS2 KLHL22 VPS13D NUP210 PLCD1 | 3.46e-06 | 196 | 178 | 10 | 5806_DN |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | MON2 PAPPA2 PCDHGA1 ITGA10 ARFGEF1 TEX15 ADGRA2 PCNX2 XYLB CRBN | 3.78e-06 | 198 | 178 | 10 | 4783_UP |
| Disease | mental development measurement | 4.86e-09 | 25 | 167 | 6 | EFO_0008230 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 6.99e-09 | 71 | 167 | 8 | EFO_0007878, EFO_0007979 | |
| Disease | Sarcosine measurement | 1.69e-07 | 23 | 167 | 5 | EFO_0021668 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.78e-07 | 3 | 167 | 3 | C1842563 | |
| Disease | lymphocyte count | RAD51B EXOC6 MMS22L GBF1 PCDHGC4 CYP3A5 PCDHGA10 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 COBLL1 ENC1 NOC3L CCDC92 PLEKHA6 UBASH3A GTF2IRD2B GTF2IRD2 CYP4F3 ABCD1 TUBD1 CLEC16A NUP160 | 8.10e-07 | 1464 | 167 | 25 | EFO_0004587 |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 3.18e-05 | 2 | 167 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 3.18e-05 | 2 | 167 | 2 | cv:C1832390 | |
| Disease | Periventricular gray matter heterotopia | 3.18e-05 | 2 | 167 | 2 | C1849173 | |
| Disease | common carotid intimal medial thickness | 3.98e-05 | 67 | 167 | 5 | EFO_0004860 | |
| Disease | Fanconi anemia | 6.19e-05 | 14 | 167 | 3 | cv:C0015625 | |
| Disease | Congenital abnormality of respiratory system | 9.52e-05 | 3 | 167 | 2 | C0035238 | |
| Disease | Bone marrow hypocellularity | 1.36e-04 | 18 | 167 | 3 | C1855710 | |
| Disease | intraocular pressure measurement | RAD51B EXOC6 PCDHGA5 WNT9B NPLOC4 TGFB2 OR4C15 ZNF516 TANGO2 NUP160 NPAS2 | 1.63e-04 | 509 | 167 | 11 | EFO_0004695 |
| Disease | Colorectal Carcinoma | RALGDS SATB2 ARFGEF1 AKAP3 APOB BRINP1 RET DCC LIFR PTPRN2 TLR4 DCHS1 PZP | 1.92e-04 | 702 | 167 | 13 | C0009402 |
| Disease | Loeys-Dietz Syndrome, Type 1a | 3.15e-04 | 5 | 167 | 2 | C4551955 | |
| Disease | Loeys-Dietz Aortic Aneurysm Syndrome | 3.15e-04 | 5 | 167 | 2 | C1836635 | |
| Disease | noise-induced hearing loss | 3.15e-04 | 5 | 167 | 2 | EFO_1001254 | |
| Disease | household income | 3.56e-04 | 304 | 167 | 8 | EFO_0009695 | |
| Disease | Fanconi Anemia | 3.74e-04 | 25 | 167 | 3 | C0015625 | |
| Disease | free cholesterol in very large VLDL measurement | 4.02e-04 | 61 | 167 | 4 | EFO_0022274 | |
| Disease | Pancytopenia | 4.21e-04 | 26 | 167 | 3 | C0030312 | |
| Disease | phospholipids in large VLDL measurement | 4.28e-04 | 62 | 167 | 4 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 4.28e-04 | 62 | 167 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 4.28e-04 | 62 | 167 | 4 | EFO_0022299 | |
| Disease | glucagon measurement, glucose tolerance test | 4.71e-04 | 6 | 167 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | cognitive function measurement | RAD51B DMXL2 MMS22L GBF1 TMPRSS13 PPP2R2D PCDHGA5 BRINP1 DCC GTDC1 ADGRA2 FAM135B RYR3 MEI4 KCNG2 PTPRN2 LRRC7 ADGRA3 NPAS2 | 5.11e-04 | 1434 | 167 | 19 | EFO_0008354 |
| Disease | cholesterol in large VLDL measurement | 5.12e-04 | 65 | 167 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 5.12e-04 | 65 | 167 | 4 | EFO_0022230 | |
| Disease | total lipids in large VLDL | 5.75e-04 | 67 | 167 | 4 | EFO_0022175 | |
| Disease | Miller Dieker syndrome | 5.84e-04 | 29 | 167 | 3 | C0265219 | |
| Disease | wellbeing measurement | FAT4 MMS22L NPY1R MFHAS1 ARFGEF2 BRINP1 TEX15 DCC KCNG2 TLR4 HERC1 NUP160 | 6.07e-04 | 692 | 167 | 12 | EFO_0007869 |
| Disease | free cholesterol in large VLDL measurement | 6.08e-04 | 68 | 167 | 4 | EFO_0022265 | |
| Disease | cortical surface area measurement | MON2 RAD51B EXOC6 ITGA11 SATB2 PDE3A PCNX3 MFHAS1 FAT3 EYA1 ADGRA2 FRMD4B NPLOC4 SLC38A2 MACF1 QSER1 ZSWIM4 PDZD2 | 6.43e-04 | 1345 | 167 | 18 | EFO_0010736 |
| Disease | Loeys-Dietz Syndrome | 6.56e-04 | 7 | 167 | 2 | C2697932 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 6.65e-04 | 122 | 167 | 5 | EFO_0004318, EFO_0007789 | |
| Disease | mood instability measurement | 8.26e-04 | 128 | 167 | 5 | EFO_0008475 | |
| Disease | Abnormality of radial ray | 8.57e-04 | 33 | 167 | 3 | C4228778 | |
| Disease | fatty acid measurement | 8.88e-04 | 436 | 167 | 9 | EFO_0005110 | |
| Disease | melanoma (is_implicated_in) | 9.37e-04 | 34 | 167 | 3 | DOID:1909 (is_implicated_in) | |
| Disease | smoking status measurement | MON2 MMS22L GBF1 NRAP FAT3 BRINP1 DCC KCNG2 FANCF HHLA2 PTPRN2 TLR4 QSER1 HERC1 MDGA1 CRBN | 9.44e-04 | 1160 | 167 | 16 | EFO_0006527 |
| Disease | cognitive function measurement, self reported educational attainment | 9.80e-04 | 355 | 167 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.00e-03 | 200 | 167 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | posterior thigh muscle fat infiltration measurement | 1.02e-03 | 35 | 167 | 3 | EFO_0020934 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.39e-03 | 10 | 167 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | Fanconi anemia (is_implicated_in) | 1.39e-03 | 10 | 167 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | waist-hip ratio | RAD51B PAPPA2 COL6A2 VPS11 DMXL2 MMS22L ITGA11 COL15A1 COBLL1 ARFGEF1 CCDC92 EYA1 KIAA2013 ABCB9 CLEC16A NPAS2 | 1.67e-03 | 1226 | 167 | 16 | EFO_0004343 |
| Disease | central corneal thickness, intraocular pressure measurement | 1.69e-03 | 11 | 167 | 2 | EFO_0004695, EFO_0005213 | |
| Disease | Cleft palate, isolated | 1.74e-03 | 42 | 167 | 3 | C1837218 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 2.01e-03 | 398 | 167 | 8 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | NRAP BRINP1 DCC FAM135B KCNG2 HHLA2 MGAT5 PTPRN2 TLR4 PRKDC HERC1 CRBN | 2.10e-03 | 801 | 167 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 2.11e-03 | 95 | 167 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | interleukin 7 measurement | 2.12e-03 | 45 | 167 | 3 | EFO_0008189 | |
| Disease | metachronous colorectal adenoma | 2.12e-03 | 45 | 167 | 3 | EFO_0803377 | |
| Disease | Adenocarcinoma of large intestine | 2.19e-03 | 96 | 167 | 4 | C1319315 | |
| Disease | Ischemic stroke | 2.56e-03 | 324 | 167 | 7 | HP_0002140 | |
| Disease | neurotic disorder | 2.64e-03 | 101 | 167 | 4 | EFO_0004257 | |
| Disease | unipolar depression, anxiety | 2.77e-03 | 14 | 167 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.77e-03 | 14 | 167 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 3 measurement | 2.81e-03 | 169 | 167 | 5 | EFO_0600056 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.87e-03 | 50 | 167 | 3 | EFO_0022247 | |
| Disease | melanoma | 2.97e-03 | 248 | 167 | 6 | C0025202 | |
| Disease | childhood onset asthma | 3.03e-03 | 334 | 167 | 7 | MONDO_0005405 | |
| Disease | disease recurrence, colon carcinoma | 3.04e-03 | 51 | 167 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.14e-03 | 106 | 167 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.59e-03 | 110 | 167 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.59e-03 | 110 | 167 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.59e-03 | 110 | 167 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | leptin measurement, type 2 diabetes mellitus | 3.63e-03 | 16 | 167 | 2 | EFO_0005000, MONDO_0005148 | |
| Disease | unipolar depression | OTOA ITGA11 MFHAS1 ARFGEF2 BRINP1 EYA1 DCC FAM135B KCNG2 NLRP9 TLR4 DCHS1 XYLB QSER1 PZP | 3.65e-03 | 1206 | 167 | 15 | EFO_0003761 |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.71e-03 | 111 | 167 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | triglycerides in medium VLDL measurement | 3.76e-03 | 55 | 167 | 3 | EFO_0022155 | |
| Disease | triglycerides in large VLDL measurement | 3.96e-03 | 56 | 167 | 3 | EFO_0022178 | |
| Disease | triglycerides in very large VLDL measurement | 3.96e-03 | 56 | 167 | 3 | EFO_0022325 | |
| Disease | Pulmonary Emphysema | 4.10e-03 | 17 | 167 | 2 | C0034067 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.10e-03 | 17 | 167 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 4.10e-03 | 17 | 167 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | RALGDS PCDHGA5 BACH1 ENC1 APOB NPLOC4 NLRP3 EPG5 GTF2IRD2B FANCI NUP210 ZNF516 GTF2IRD2 HERC1 TUBD1 HSP90AB1 | 4.21e-03 | 1347 | 167 | 16 | EFO_0005192 |
| Disease | FEV/FEC ratio | RAD51B PDE3A COL15A1 PCDHGA5 PCDHGA1 NOC3L BRINP1 EYA1 DCC NPLOC4 TGFB2 MGAT5 ZNF516 HERC1 CLEC16A | 4.31e-03 | 1228 | 167 | 15 | EFO_0004713 |
| Disease | triglycerides in VLDL measurement | 4.59e-03 | 59 | 167 | 3 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 4.59e-03 | 59 | 167 | 3 | EFO_0022301 | |
| Disease | retinal layer thickness measurement | 4.81e-03 | 60 | 167 | 3 | EFO_0600002 | |
| Disease | total lipids in VLDL measurement | 4.81e-03 | 60 | 167 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.81e-03 | 60 | 167 | 3 | EFO_0022233 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 5.03e-03 | 121 | 167 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | triglycerides in small VLDL measurement | 5.04e-03 | 61 | 167 | 3 | EFO_0022145 | |
| Disease | free cholesterol in VLDL measurement | 5.04e-03 | 61 | 167 | 3 | EFO_0022276 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 5.11e-03 | 19 | 167 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | diet measurement, HOMA-B | 5.11e-03 | 19 | 167 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | triglyceride measurement, body mass index | 5.11e-03 | 19 | 167 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 5.11e-03 | 19 | 167 | 2 | DOID:4928 (is_marker_for) | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 5.33e-03 | 123 | 167 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | urinary microalbumin measurement | 5.66e-03 | 20 | 167 | 2 | EFO_0010967 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYSESTSLAEKLLSH | 141 | Q5TYW2 | |
| ISVEDLSSYLHTAGL | 1196 | Q9UMD9 | |
| HQTLALHSYTSVLSR | 376 | Q9HCE0 | |
| YESSVHSTNVLLSLN | 11 | O14867 | |
| SYTALLDLSHNNLSR | 61 | Q86WK6 | |
| NLHSGLREYTLTSAL | 161 | Q6DCA0 | |
| GLTHELVQSLISTYS | 111 | Q5VTM2 | |
| VYSESTSLAEKLLSH | 141 | Q5CZ79 | |
| DSRLYVHTTFISNEI | 496 | O60477 | |
| QAVGITLHYSSLSTL | 836 | Q96PE1 | |
| SSVLSFTLYELATHP | 311 | P20815 | |
| VYSESTSLAEKLLSH | 141 | Q4UJ75 | |
| LTGSELYTQAASLLH | 746 | Q8IWK6 | |
| ALSYFLTLTSESHRE | 1761 | Q9Y6D6 | |
| TYRLSESHALFAINS | 71 | Q6V0I7 | |
| IFLNILETSTSSFEH | 481 | Q9Y6D5 | |
| EILTSEFSYQHSLSI | 291 | Q5VV41 | |
| IINFDTSLPTSHTYL | 46 | Q96SW2 | |
| INSISVNSDHETYLS | 186 | Q66LE6 | |
| VSQLYSFSTSLVHSI | 1451 | Q9UKA4 | |
| LIHALATNSSSELFR | 2356 | Q8TDJ6 | |
| YLTTLGQRLAHISTD | 866 | Q7L2E3 | |
| KNDSSFLSTLHEVYL | 556 | Q9NPI6 | |
| SSYTIDLLSAEQNHI | 96 | Q53SF7 | |
| TYSSLHASENRELLN | 246 | Q8IZT6 | |
| TDTLYDEILQHSSLC | 366 | Q9ULI1 | |
| SVTSLHSFQVIESLY | 86 | Q8TAI7 | |
| SHSVNTRLILQYLDS | 301 | O15315 | |
| STQDTVVALHALSRY | 1256 | P20742 | |
| NLYRTHIDIIGSSSD | 326 | Q6ZSC3 | |
| VRAFLQTYSHEVSLT | 746 | Q9Y5H1 | |
| SSTYRSAQESAPHLL | 131 | Q2KHR3 | |
| VRAFLQTYSHEVSLT | 746 | Q9Y5G8 | |
| DRFSESILTYVAHTS | 186 | Q92932 | |
| LHSEQQDSLLLSTYS | 771 | Q99743 | |
| VYSESTSLAEKLLSH | 141 | Q5SQ80 | |
| LHSAALVSRTFLSVY | 96 | P33897 | |
| VTSSLELIDLHFSDY | 396 | Q8NFP4 | |
| LTYSQLESLSPEAVH | 411 | Q7RTW8 | |
| SDSHNALRILTFLES | 171 | Q8TEM1 | |
| AEILLSNHYTSSEIR | 1696 | Q8TEM1 | |
| SSLLTALFRDSIQSH | 811 | Q9NVI1 | |
| SFTLSHYRVAVTEDL | 2481 | Q96JQ0 | |
| TTISFALEEYLVSHA | 56 | O95340 | |
| YSIERLESSSHYVIS | 781 | P43146 | |
| LSELLRYHTSQSGDE | 451 | P08238 | |
| SYAVILLSLRTHSSE | 216 | Q8NGM1 | |
| VRAFLQTYSHEVSLT | 746 | Q9Y5G7 | |
| QHLDRFSELLAVSST | 6 | Q9NPI8 | |
| LLQYSTQVHTEFTLR | 696 | O00339 | |
| TEDRLQSALSYLHES | 696 | Q9Y4C4 | |
| TSLYLLGHDIRISAS | 306 | Q09328 | |
| ISLAHSVYATSLQSD | 1086 | Q86VF7 | |
| STIGYLHSLRTLAVD | 316 | Q96NW7 | |
| TETALVNSSRELFHL | 81 | Q6ZRQ5 | |
| SLTAESRLVHTSPNY | 1491 | Q15751 | |
| ISRDTHEASFLSALY | 1626 | Q5CZC0 | |
| HTLLTYATRDDLIYT | 1246 | O95382 | |
| NSIFYEHLTRTLQES | 1386 | A6NKB5 | |
| LLVALSYHLSRQSSD | 991 | Q9H6A9 | |
| VTSIFHTFSRSYSEL | 401 | Q9UJ96 | |
| RAFLQTYSHEVSLTA | 751 | Q9Y5H3 | |
| LSSAIYSRLLSIHET | 301 | P09131 | |
| ASLVYLNESSVLHTL | 411 | Q92614 | |
| QLLDSSSASQEYHIV | 546 | O15018 | |
| SHRALTYTQSAPDLS | 561 | Q14432 | |
| TSSVFLDTISDFHLL | 496 | Q8TAT6 | |
| ETIIVFHSLLTGSYA | 331 | Q99502 | |
| LCNISSDEYTLLTIH | 316 | Q9UM44 | |
| VNLDTYTSDLHFQVS | 246 | Q1KMD3 | |
| GLQTLDSAALYHLTT | 161 | Q8N7C0 | |
| DSAALYHLTTLETLF | 166 | Q8N7C0 | |
| ARLDVHALYTTSTGL | 736 | Q2VPB7 | |
| DVLFTRSSSLSHYEV | 956 | Q9UKX5 | |
| HYALTVLNTTTAATL | 616 | Q7Z3U7 | |
| SISSYRLSSNEHFAL | 166 | Q9Y5F7 | |
| HYSLFLQTLLSSSGA | 526 | Q9H8H2 | |
| QRSLSTSGESLYHVL | 6 | Q9H3Z4 | |
| IYASLKFSESLHRSS | 496 | Q8TAG9 | |
| QETVHTTRLYGLSTF | 576 | Q8TAG9 | |
| NISYINESELTGLHS | 71 | Q7Z2Q7 | |
| TDSILSHFQSLSYSL | 4086 | Q9UPN3 | |
| RAQLTFEYLHTNSTT | 11 | Q9Y6X9 | |
| LVSSSHNTYLLEDQL | 306 | P51178 | |
| VRAFLQTYSHEVSLT | 746 | Q9Y5H0 | |
| RSEQYLTLSGAHDLS | 836 | O43182 | |
| QFPSDSHRLSYTTLL | 201 | P25929 | |
| TVTLYLTDVRGSNHS | 1296 | Q9BXP8 | |
| SYALILSSILHNSST | 216 | Q8NGG6 | |
| TPVLTRNAYSSSHLE | 666 | Q9Y2L6 | |
| VYSESTSLAEKLLSH | 141 | Q5VUR7 | |
| AVDHKLSLESLTSYF | 3476 | P04114 | |
| RVHSYNASETSQLLS | 126 | Q7L8L6 | |
| LSSHTQYRTAFETII | 241 | A4D1E9 | |
| HFIYTSELELSLSNV | 106 | Q53GT1 | |
| YDHENASTLILTPTS | 761 | P51587 | |
| EELSQASLDSITHRY | 101 | Q96LM5 | |
| TELHNLASRTEYLVS | 431 | Q9P218 | |
| RASTIAYLTSQLHAA | 151 | Q53HC0 | |
| QLFHSVTDTVDYSLA | 1151 | Q5TH69 | |
| FTELTRLYLTIHSDH | 251 | O75390 | |
| IHEALETTQYLNSFS | 901 | P12110 | |
| YFHIDSSSGLILTAR | 2336 | Q8TDW7 | |
| LNASRSLEVSYVTDH | 366 | P01880 | |
| SLALDYLQVSLSHIT | 71 | Q96GE4 | |
| SLYAILSALQSNSIH | 481 | Q12967 | |
| LLFSSESTLHRYEVH | 941 | O75578 | |
| VSGQLYTTHLLSLDA | 566 | Q92538 | |
| YFATIHTDSSLLLAD | 141 | Q9Y2T3 | |
| HRDSSYYLAVSDLTL | 206 | P13584 | |
| LIHSSEEGLLYTQSL | 66 | Q08477 | |
| SSYADSVLTHLNLLR | 26 | O14682 | |
| FLDTVTLHSQVTTYL | 321 | Q49AJ0 | |
| THSQLSLDIRNSEYL | 371 | Q49AJ0 | |
| LNHSEFTTLLYELDS | 686 | Q86UP8 | |
| LNHSEFTTLLYELDS | 686 | Q6EKJ0 | |
| SEHYRTLFASSVLNL | 56 | Q4AE62 | |
| LLSTYRAFLSSHLQD | 1246 | P39059 | |
| SVLLTSYTHSAVDNI | 671 | P51530 | |
| LEEHTSTLLLNGYQT | 266 | O75995 | |
| STSLDHALERTYQLL | 196 | O75309 | |
| ILNLSADFSTSTLYL | 141 | P42702 | |
| ELTGSTNLITHYNLE | 76 | A0JLT2 | |
| LHTLIESGDLSYQES | 541 | Q8WTT2 | |
| VRAFLQTYSHEVSLT | 746 | Q9Y5H4 | |
| LSTSHSLTRLYVGEN | 851 | Q96P20 | |
| LASLISDYNLSSHIL | 216 | A8MW99 | |
| SLNVTTSAYLESLHG | 626 | O95197 | |
| HTEYSLLSLLHTQDG | 91 | Q8N2I9 | |
| SLRSHGVLLEVQYSS | 176 | Q8WV92 | |
| ISSSHNTYLVSDQLL | 166 | Q86YW0 | |
| LTGYLHTISSENLLD | 486 | Q9NYY8 | |
| HTISSENLLDAVYSF | 491 | Q9NYY8 | |
| HGSNSSLYLQLVETS | 86 | Q8N165 | |
| LVETALLALGYSHSS | 96 | Q9UPW6 | |
| RSGTTVLHAYLQTLS | 201 | Q8N8Z3 | |
| HSLQLSETNRTLYLF | 191 | Q13046 | |
| TESNRYSLDHISSLF | 376 | Q12769 | |
| YSLDHISSLFTSQET | 381 | Q12769 | |
| TTAIYVFSHLDRSLL | 21 | Q9NP78 | |
| SDLIDSFLRNLHSVT | 331 | O75969 | |
| STIFLDDSTASQHYL | 146 | A6NIR3 | |
| ENISHETSLYYLLSN | 106 | Q2KHT3 | |
| SLYGTSLSQSDIRHL | 691 | Q7RTR0 | |
| SDTQHSRVLSLYNTI | 356 | P61812 | |
| NSILTLSHLYRSSDA | 186 | Q9UJT1 | |
| ATTALTNSTIEYEHL | 606 | Q9Y2H5 | |
| SYATLREESLLSHIE | 206 | Q92618 | |
| LHITASQLSDSASYI | 96 | A0A0B4J240 | |
| DSHLQRIISSDVYTA | 501 | Q9P217 | |
| LLDATINAYINTTHS | 1111 | Q9P217 | |
| SDHSEILDTTNSYLI | 756 | O75762 | |
| YLATVRSDLSTFHLL | 191 | O95070 | |
| AHNSTATLSVIRDYL | 761 | Q9H270 | |
| FSILRYNSTIQESLH | 286 | Q9BYE2 | |
| HLEFSHSYEERTLLT | 46 | Q70YC5 | |
| LISSIFDFSHSLSAL | 396 | P51449 | |
| ASTQYHDISTELAIS | 391 | Q0IIM8 | |
| SELLHTYSSILGTDI | 356 | Q96QD8 | |
| EHCTSLIDSTLQTIY | 2436 | Q15413 | |
| LTAHYSAVTSLAFSA | 191 | Q12788 | |
| LLAESEALTSYSHRV | 281 | Q7Z404 | |
| AYSHTERISLVSSFA | 186 | O75191 | |
| TYLSSHSSDFIELCL | 156 | Q96DC7 | |
| RYIISGDTQSHSTLA | 106 | A6NKC9 | |
| HSLQINSSLSTYSLV | 81 | Q5VZM2 | |
| TTSNHSRYVATDINL | 466 | Q68DE3 | |
| LENYSHLISLGSSIS | 36 | O75290 | |
| LENYSHLISLGSSIS | 36 | Q9Y6R6 | |
| LTSADHLYVNVSELS | 251 | P48023 | |
| FSVNSSSESLNHLLY | 551 | P78527 | |
| DTGLLYLNRSLDHSS | 91 | P07949 | |
| QSSSVSVEHSYALLL | 646 | Q5VWN6 | |
| SQSDLTLHSEIAYIS | 1551 | Q9BXT5 | |
| SSHYFQSLEVTTHIL | 251 | Q9BR11 | |
| FLISSKRSNHYSLST | 376 | A6NGJ6 | |
| TAFLYAVSSAALTHT | 116 | O14905 | |
| GAYQSLSHLSTLILT | 96 | O00206 | |
| FLISSKRSNHYSLST | 376 | A6NI03 | |
| LRSADTTHSTVLGLY | 351 | P10600 | |
| ASQFRTASTYISHLE | 976 | Q6ZSZ6 | |
| LVTHFLTTDVDSLSY | 91 | Q6ICL3 | |
| LSNLTRASFVSHYIL | 206 | P57075 | |
| SSLESYLQTELHLYT | 196 | O43264 | |
| LDAAVTAYITTSHSR | 916 | Q9H7M6 | |
| STASLTNLEHQIYAR | 2861 | Q5THJ4 | |
| YISTDLTHLQDLRHT | 556 | Q8IYS2 | |
| SLSSEYLSTSLLHNK | 886 | Q86W24 | |
| TTTHAVAILFYTLNS | 116 | Q93070 |